Based on our model, where high ACTL6A expression reduces p21Cip1, we interpret these results as suggesting that the tumor samples express enough ACTL6A to partially, but not completely suppress, p21Cip1 expression. The gene discussed is ACTL6A; the disease is neoplasm.